🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Bindu Santhamma

Evestra (United States)

ORCID: 0000-0002-5569-2185
Biochemistry, Genetics and Molecular BiologyMedicineMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Table from A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22432374.v1
Top 100%
0DataRank
Top 100%0 citations

Suryavathi Viswanadhapalli, Monica Mann, Dimple Chakravarty, Samaya Krishnan, Zexuan Liu +21 more

Papers

Driven by 10 papers — median percentile 0. Top paper: “EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling”.

EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling

Journal of Molecular Cell Biology(2020)10.1093/jmcb/mjaa008
N/A
0DataRank · unranked
18 citations

Fangnan Wu, Jianming Wang, Kaitlin Kim, Bindu Santhamma, K.V. Dileep +8 more

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer

Communications Biology(2021)10.1038/s42003-021-02741-7
N/A
0DataRank · unranked
23 citations

Suryavathi Viswanadhapalli, Bindu Santhamma, Uday P. Pratap, Yiliao Luo, Junhao Liu +21 more

A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-0698
N/A
0DataRank · unranked
27 citations

Suryavathi Viswanadhapalli, Monica Mann, Dimple Chakravarty, Samaya Krishnan, Zexuan Liu +21 more

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth

Cancers(2022)10.3390/cancers14215400
N/A
0DataRank · unranked
9 citations

Uday P. Pratap, Xue Yang, Zexuan Liu, Kristin A. Altwegg, Bindu Santhamma +13 more

The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling

International Journal of Molecular Sciences(2023)10.3390/ijms242417426
N/A
0DataRank · unranked
13 citations

Alondra L. Rodriguez Sanchez, Rahul Gopalam, Panneerdoss Subbarayalu, Daisy Medina, Xue Yang +11 more

Supplementary Table from A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22432374.v1
Top 100%
0DataRank
Top 100%0 citations

Suryavathi Viswanadhapalli, Monica Mann, Dimple Chakravarty, Samaya Krishnan, Zexuan Liu +21 more

Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis

npj Precision Oncology(2024)10.1038/s41698-024-00612-y
N/A
0DataRank · unranked
20 citations

Suryavathi Viswanadhapalli, Uday P. Pratap, Gopalam Rahul, Xue Yang, Prabhakar Pitta Venkata +19 more

Significance of LIF/LIFR Signaling in the Progression of Obesity-Driven Triple-Negative Breast Cancer

Cancers(2024)10.3390/cancers16213630
N/A
0DataRank · unranked
4 citations

Jaitri Joshi, Alondra L. Rodriguez Sanchez, Uday P. Pratap, Rahul Gopalam, Yidong Chen +8 more

Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis

Cancers(2025)10.3390/cancers17050790
N/A
0DataRank · unranked
1 citations

Zenaida Fuentes, Lois Randolph, Megharani Mahajan, Emily J. Aller, Behnam Ebrahimi +9 more

EC359 Enhances Trametinib Efficacy in Ras/Raf-Driven Ovarian Cancer by Suppressing LIFR Signaling

Biomolecules(2025)10.3390/biom15101396
N/A
0DataRank · unranked
0 citations

Durga Meenakshi Panneerdoss, Baskaran Subramani, Megharani Mahajan, Behnam Ebrahimi, Paulina Ramirez +9 more